TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: knee flexion angles
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: stance duration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to reach MobIs ≥13
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Opioid-free status before discharge
Endpoint domain: Adverse events/effects
Primary endpoint: Behavioral Involvement
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Competence
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Lower limb power
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Plasma LDL cholesterol concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: MRA prescribing rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Coronal stiffness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Axial overall stiffness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Revision recommendation rate
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Reduction in transfusion burden
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Intraoperative fluid input
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Circulating chemerin levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: rehabilitation (attaining supervised and unsupervised leave)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PD symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 5-IRGPs signature as a prognostic marker for survival
Endpoint domain: Mortality/survival
Primary endpoint: Usual gait speed (UGS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Receipt of SUD treatment within 30 days
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Efficacy of PGx-guided treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: proportion of patients in LDA at 12 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Feasibility and acceptability of home-based cognitive training intervention
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Total score of the general well-being scale
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Total score of adolescent mental resilience scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: EC90 of ropivacaine
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: irreversible nerve injury
Endpoint domain: Adverse events/effects
Primary endpoint: Social interaction problems
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: General psychopathology
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Parental satisfaction with diabetes treatment
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Dwell time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Phlebitis scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Decrease in mRNA expression of RORγt
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Decrease in mRNA expression of IL-17
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Improvement in IQoL-32
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Maximal peri-operative blood glucose concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: weighted adequate health literacy (HL)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: MMSE total score change
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Prevalence of suspected mild cognitive impairment
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Mean change in body sway from baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: NPQ scores of cervical symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of participants achieving a PASI of 2 or lower
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: knowledge about extracorporeal membrane oxygenation
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: mineral density
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: osteoid percentage
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in vastus medialis CSA at 24 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Muscle strength at 24 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Reduction in at-risk drinking
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: acute grade III-V toxicities
Endpoint domain: Adverse events/effects
Primary endpoint: Noise intensity inside the helmet
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Perception of noise inside the helmet
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Interest and enjoyment
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Mean bias between PaCO2 and PETCO2
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: 4-month weight loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: real-time data sharing benefits
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: improved consultations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: better clinical input and support
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rates of intrapartum antibiotic prophylaxis for preventing early-onset group B Streptococcus infection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Neonatal exposure to antibiotics
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Sensitivity and specificity of the rapid test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CRK contamination rate
Endpoint domain: Adverse events/effects
Primary endpoint: Differentially expressed immune-related gene sets
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Expression of FOXP3 + tumor infiltrating lymphocytes (TILs)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Total SDQ scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Hyperactivity scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Conduct problems scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Formation of beta-amyloid (Aβ) plaque and neurofibrillary (NF) tangles
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: 24-hour IV crystalloid fluid volumes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Infant retention in the study
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: grades of skin reactions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: functional health and wellbeing status
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Gray Matter Volume (GMV) in the right dorsal medial prefrontal cortex (dMPFC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Anti-inflammatory IL-10 levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Overall accuracy of ultrasound for ETT placement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean time to identification of ETT location
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean operator confidence score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Ages and Stages Questionnaire total score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Infant-Toddler Social and Emotional Assessment externalizing domain score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Risk of scoring 1.5 SDs or more on the externalizing domain score
Endpoint domain: Adverse events/effects
Primary endpoint: Rate of subjects achieving MCID
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Number of days without rescue medications
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: IDQOL improvement
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Reduction in scores on the Yale‐Brown Obsessive‐Compulsive Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Renal function change after 6 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Positive surgical margins
Endpoint domain: Adverse events/effects
Primary endpoint: recurrences in the tumor bed and contralateral breast event
Endpoint domain: Mortality/survival
Primary endpoint: acute grade 3 toxicities (radiation dermatitis)
Endpoint domain: Adverse events/effects
Primary endpoint: late grade ≥ 2 events
Endpoint domain: Adverse events/effects
Primary endpoint: Trunk fat mass
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Dual-task walking ability improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: level of self-care
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: use of adaptive coping strategies
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: posttreatment reductions in avoidance behavior
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Length of Stay (LOS) in Hospital
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Length of Stay (LOS) in ICU
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: social participation
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: self-reported leisure time MVPA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: accelerometer-assessed MVPA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: incident ovarian cancer
Endpoint domain: Mortality/survival
Primary endpoint: satisfaction about life
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: comfort in eating any food
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: hand strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ΔMAGE (Mean Amplitude of Glycemic Excursion)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Postoperative atrial fibrillation (POAF) occurrence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Optimal formulation parameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Anaerobic powers
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: MADRS score reductions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Gut microbiota composition and activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fecal metabolomics features
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Willingness to join community-based care program
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Protocol deviations in delineation of WPRT
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Adherence to treatment protocol
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Variability in dose normalization for SBRT
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Intra-abdominal fat area loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Outcome after surgery for bowel obstruction or gastrointestinal perforation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Ability to learn skills for powered wheelchair operation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Risk of AECOPD
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Bioavailability of elacestrant
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean half-life of elacestrant
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Safety profile of elacestrant
Endpoint domain: Adverse events/effects
Primary endpoint: Incomplete wound healing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ischemic Stroke
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Incidence of Brooker grade 3 heterotopic ossification
Endpoint domain: Adverse events/effects
Primary endpoint: Vaping knowledge
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Perceptions of risk
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Anti-vape intentions
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: relative operator dose
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: left finger radiation dose
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: FTND score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: MNWS score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Intensity score for phonic tics
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean total analgesic consumption
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in dichotomized direct TAVEC
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Improvement in dichotomized delayed Centil REY copy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Amyloid-beta deposition analysis in anterior cingulate gyrus
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Incremental cost per quitter
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Percentage change in bone mineral density (BMD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain score at 6th and 12th hours postoperatively
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: stability of heart rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Follistatin levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sex hormone binding globulin (SHBG) levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Overactive bladder questionnaire (OABq) score improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum bladder capacity improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Post void residue (PVR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Global Impression of Change (PGIC) > 50%
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Optimal Treatment Response (PGIC ≥ 90%)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Hospitalization rates in category 1 patients
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Improvement in symptom and mood measures
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Improvement in self-described cognitive symptoms
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Mean rate of perceived exertion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement of bone erosion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Improvement of tendon thickening
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Serum levels of TNF‐α and IL‐33
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Stroke volume change after blood donation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Percentage of sites with probing depth >6 mm
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of pocket closure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Overall knowledge based on answers
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: VAS score after premedication
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Translational mean setup variation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Systematic setup error
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Random errors
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total number correct responses on the Stroop task
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cognitive functioning
Primary endpoint: Average reaction time of correct colour‐words
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cognitive functioning
Primary endpoint: screening uptake rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 4-year implant survival rate
Endpoint domain: Mortality/survival
Primary endpoint: mean sinus elevation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: patient-reported discomfort
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Bone Mineral Density (BMD) at total hip and spine
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Confidence in decision-making skills
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Communication with partners and caregivers
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Access to sexual education
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: 24 hours postoperative visual analog scale (VAS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: total postoperative morphine consumption
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: mean blood pressure (mean arterial pressure [MAP])
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: IBS degree of relief
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Time to first spontaneous bowel movement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Duration of current episode
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Obesity/overweight
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: SF-36 general health scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: 1 minute-APGAR score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in Overactive Bladder Symptoms (OAB-q)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in International Prostate Symptom Score (IPSS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Erectile Function (IIEF-5)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Perceived distress
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Reduction in adult-mosquito density
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maternal knowledge
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Parenting confidence levels
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Contrast sensitivity with glare
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Glare recovery time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: UFOV divided attention test scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes